Evolving Strategies in Typhoid Prevention and Control: Recent Advancements and Future Directions

Jugal  Kishore; Kanika  Paruti; Deep  Priya Lall

Jugal Kishore Director Professor, Department of Community Medicine, VMMC & Safdarjung Hospital, New Delhi, India.
Kanika Paruti Senior Resident, Department of Community Medicine, VMMC & Safdarjung Hospital, New Delhi, India.
Deep Priya Lall Senior Resident, Department of Community Medicine, Lady Hardinge Medical College, New Delhi, India.

Keywords: Typhoid Fever, Typhoid Conjugate Vaccine, Prevention, Control, India, NTAGI, Antimicrobial Resistance, COVID-19, Public Health

Abstract

Typhoid fever remains a significant global health challenge, especially in regions lacking access to clean water and sanitation. Recent advancements in prevention and control strategies, notably the introduction of the Typhoid Conjugate Vaccine (TCV), have spurred renewed efforts to combat this infectious disease. This comprehensive review explores key insights, including recommendations, hurdles, cross-country experiences and emerging trends, with a focus on India’s experience amid the COVID-19 pandemic. Strategies encompass a multifaceted approach, ranging from vaccination initiatives guided by the National Technical Advisory Group on Immunisation (NTAGI) to enhanced surveillance methodologies and targeted interventions. Despite challenges such as vaccine hesitancy and resistance to antibiotics, the integration of TCV holds promise in reducing the burden of typhoid and improving public health outcomes. As India adapts to post-pandemic dynamics, proactive measures aimed at strengthening healthcare infrastructure and refining disease control strategies are essential in shaping a resilient response to infectious diseases like typhoid.

How to cite this article:
Kishore J, Paruti K, Lall D P. Evolving Strategies
in Typhoid Prevention and Control: Recent
Advancements and Future Directions. J Commun
Dis. 2024;56(3):169-171.

DOI: https://doi.org/10.24321/0019.5138.202460

References

World Health Organization. Typhoid vaccines: WHO position paper, March 2018 - recommendations. Vaccine. 2019 Jan 7;37(2):214-6. [PubMed] [Google Scholar]

John J, Bavdekar A, Rongsen-Chandola T, Dutta S, Gupta M, Kanungo S, Sinha B, Srinivasan M, Shrivastava A, Bansal A, Singh A, Koshy RM, Jinka DR, Thomas MS, Alexander AP, Thankaraj S, Ebenezer SE, Karthikeyan AS, Kumar D, Njarekkattuvalappil SK, Raju R, Sahai N, Veeraraghavan B, Murhekar MV, Mohan VR, Natarajan SK, Ramanujam K, Samuel P, Lo NC, Andrews J, Grassly NC, Kang G; NSSEFI Study Team. Burden of typhoid and paratyphoid fever in India. N Engl J Med. 2023 Apr 20;388(16):1491-500. [PubMed] [Google Scholar]

Batool R, Qamar ZH, Salam RA, Yousafzai MT, Ashorn P, Qamar FN. Efficacy of typhoid vaccines against culture-confirmed Salmonella Typhi in typhoid endemic countries: a systematic review and meta- analysis. Lancet Glob Health. 2024 Apr 1;12(4):e589- 98. [PubMed] [Google Scholar]